Google+ Badge

Friday, November 13, 2015

Cancer Research: Protein's work in eye lens suggests a way to tame cancer ♦ Oral contraceptive use associated with better outcomes in patients with ovarian cancer.

Previous oral contraceptive use associated with better outcomes in patients with ovarian cancer. Patients who develop ovarian cancer appear to have better outcomes if they have a history of oral contraceptive use.
World first blood cancer drug trial reveals life-changing results A breakthrough has been achieved with the results of the world-first clinical trial with actual patients of a new drug to treat particular blood cancers. This clinical trial, a first-in-human study, looked at the efficacy of a new inhibitor, ONO/GS-4059, in the treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma patients refractory or resistant to current chemotherapies
Preventing radiation in cancer therapies to damage healthy organs When a person receives a cancer treatment through radiation, he or she is exposed to ionizing radiation and to avoid that energy to damage healthy tissue. A new study looked at the properties of various materials called dosimeters that measure radiation doses.
Protein's work in eye lens suggests a way to tame cancer How does a protein called connexin put the clamps on cancer? Researchers have now reported an explanation. In the future, cancer therapies could potentially be based on connexin molecules.

No comments:

Post a Comment